YOUR BUSINESS AUTHORITY
Springfield, MO
CoxHealth treated its first COVID-19 patient with the experimental treatment drug remdesivir. The patient is now on the mend.
CEO Steve Edwards said it's unclear if the 22-year-old woman, who also was given plasma from people who have recovered from the virus, recuperated because of the remdesivir.
A recent federal government-sponsored study suggested remdesivir could starkly reduce recovery times for COVID-19 patients.
Read more from the Springfield News-Leader.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
State awards Springfield $4.6M for wastewater system improvements
Stockton district names next superintendent
Trump, fast-food companies among targets of X redirects
Council modifies data center definitions bill, extends moratorium into next year